Patient recruitment

StudyKIK Introduces Remote eConsent Technology Solution with Integrated Telemedicine Video Calling for Clinical Trials

Retrieved on: 
Thursday, October 1, 2020
Articles, Health, Telecommunications, Pharmaceutical industry, Assistive technology, Health informatics, Clinical research, Clinical trials, Telehealth, Patient recruitment, Cision, Videotelephony

IRVINE, Calif., Oct. 1, 2020 /PRNewswire-PRWeb/ -- StudyKIK, a full service patient recruitment & retention technology company headquartered in Irvine, CA announced today the release of their fully remote eConsent platform with Telemedicine Video Calling technology.

Key Points: 
  • IRVINE, Calif., Oct. 1, 2020 /PRNewswire-PRWeb/ -- StudyKIK, a full service patient recruitment & retention technology company headquartered in Irvine, CA announced today the release of their fully remote eConsent platform with Telemedicine Video Calling technology.
  • Given the current climate in clinical research, StudyKIK's newest eConsent technology allows clinical trials to progress while ensuring ease of consent to both participants and research facilities.
  • This innovative technology solution is offered globally and is currently being implemented on multiple crucial clinical trials.
  • The new StudyKIK eConsent with Telemedicine Video Calling technology can be used across multiple use cases including, language variations, visual impairments, hearing impairments, Consent and Assent, re-consents, and multiple video callers at once.

Biorasi Commended by Frost & Sullivan for its Full-service Offering to Drive Rare Disease Patient Recruitment for CROs

Retrieved on: 
Tuesday, September 22, 2020
Health, Pharmaceutical industry, Clinical trials, Medical research, Clinical research, Advertising, Patient recruitment, Recruitment, Medical protocol

Biorasi's milestone-based, patient-centric approach to driving patient recruitment for rare diseases, hard-to-recruit indications, and clinical trial rescues differentiate it from its peers.

Key Points: 
  • Biorasi's milestone-based, patient-centric approach to driving patient recruitment for rare diseases, hard-to-recruit indications, and clinical trial rescues differentiate it from its peers.
  • "Powered by its proprietary Talos trial management system, Biorasi advances technology-enabled protocol optimization programs, improving clinical trial performance, and success rates.
  • Beyond solving patient recruitment and engagement challenges, Biorasi addresses issues related to protocol design, clinics, and delays due to new regulations.
  • Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in devising a strong growth strategy and robustly implementing it.

Biorasi Commended by Frost & Sullivan for its Full-service Offering to Drive Rare Disease Patient Recruitment for CROs

Retrieved on: 
Tuesday, September 22, 2020
Health, Pharmaceutical industry, Clinical trials, Medical research, Clinical research, Advertising, Patient recruitment, Recruitment, Medical protocol

Biorasi's milestone-based, patient-centric approach to driving patient recruitment for rare diseases, hard-to-recruit indications, and clinical trial rescues differentiate it from its peers.

Key Points: 
  • Biorasi's milestone-based, patient-centric approach to driving patient recruitment for rare diseases, hard-to-recruit indications, and clinical trial rescues differentiate it from its peers.
  • "Powered by its proprietary Talos trial management system, Biorasi advances technology-enabled protocol optimization programs, improving clinical trial performance, and success rates.
  • Beyond solving patient recruitment and engagement challenges, Biorasi addresses issues related to protocol design, clinics, and delays due to new regulations.
  • Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in devising a strong growth strategy and robustly implementing it.

Patient Safety and Risk Management Software Markets - Global Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 17, 2020
Software, Technology, Health, Other Health, Articles, Academic disciplines, Actuarial science, Security, Health care quality, Project management, Risk management, Patient safety, Risk, Financial risk, Patient safety organization, Patient recruitment

The "Patient Safety and Risk Management Software: Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Patient Safety and Risk Management Software: Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • The market for patient safety and risk management software is expected to experience high growth during the forecast period.
  • These factors positively affect market growth for patient safety and risk management software over the forecast period.
  • The goal of risk management in healthcare services is to ensure patient safety by identifying and measuring risks to patient safety and organizational growth.

ICON Launches Accellacare a Global Clinical Research Network Focused on Increasing Patient Recruitment With a Patient Centric Approach

Retrieved on: 
Thursday, September 3, 2020
Health, Medical devices, Clinical trials, Research, Science, Pharmaceutical, Biotechnology, Clinical trials, Pharmaceutical industry, Advertising, Patient recruitment, Recruitment, Clinical, Health, Medical research, Contract research organizations, Articles, ICON plc

The site network includes previously acquired PMG Research in the US and MeDiNova Research in EMEA.

Key Points: 
  • The site network includes previously acquired PMG Research in the US and MeDiNova Research in EMEA.
  • Accellacares patient centric approach focusing on enhancing the patient experience and providing patient assessments either at site, or at home as part of integrated operations with Symphony Clinical Research, the leading global provider of at-home care and nursing for clinical trials owned by ICON, is leading to higher recruitment and retention rates.
  • Accellacare is committed to delivering on the promise of patient centricity in clinical research which is bringing benefits to both patients and sponsors.
  • Accellacare is a global clinical research network increasing patient recruitment and retention with a patient centric approach.

Trialbee Partners with Clinerion for Expanded Access to Global Real-World Data to Accelerate Patient Recruitment for Clinical Trials

Retrieved on: 
Tuesday, August 25, 2020
Professional services, Data management, Health, Technology, Insurance, Clinical trials, Health, Pharmaceutical industry, Clinical research, Articles, Clinical trials, Advertising, Patient recruitment, Recruitment

This partnership will accelerate time to market by shortening patient recruitment and enrollment timelines and will reduce costs associated with patient recruitment and loss-to-follow-up.

Key Points: 
  • This partnership will accelerate time to market by shortening patient recruitment and enrollment timelines and will reduce costs associated with patient recruitment and loss-to-follow-up.
  • This partnership significantly broadens our global reach and allows us to expand our data set for predictable intelligence-based patient recruitment and retention to support traditional and decentralized trials, said Lollo Eriksson, CEO of Trialbee.
  • And, ultimately, our improvement of the efficiency of recruitment for clinical trials will accelerate the introduction of new medicines and interventions.
  • Clinerions Patient Network Explorer also provides a platform for integration of diverse patient data sources into real-world data ecosystems.

Optime Care Speeds Patient Recruitment for Clinical Trials of Specialty Rx for Orphan & Rare Disorders, Enhances Compliance, Retention and Overall Patient Experience

Retrieved on: 
Monday, August 3, 2020
Technology, Managed care, Professional services, Infectious diseases, Science, Genetics, Clinical trials, FDA, Health, Research, Software, Other Health, Hardware, Pharmaceutical, Data management, Finance, Practice Management, Health, Articles, Pharmaceutical industry, Clinical research, Health care quality, Patient recruitment, Recruitment, Clinical trial, Patient-reported outcome, Patient advocacy, Disease registry, Patient participation

The current pandemic represents additional issues facing patients, providers and drug manufacturers in the rare and orphan disease market.

Key Points: 
  • The current pandemic represents additional issues facing patients, providers and drug manufacturers in the rare and orphan disease market.
  • These challenges include the high cost of clinical trials and patient recruitment.
  • Optime Care also adds a layer of patient advocacy, helps physicians better understand the patient journey, creates a patient registry and gives manufacturers an opportunity to obtain patient reported outcomes outside of the clinical trial protocol.
  • Our experience with small patient populations makes us uniquely qualified to help every stakeholder group impacted by these disorders.

Medable Partners With Datavant to Simplify Integration of Data Sources for Decentralized Clinical Trials

Retrieved on: 
Monday, June 29, 2020
Data management, Health, Technology, Software, Clinical trials, Biotechnology, Health, Clinical research, Medical research, Articles, Pharmaceutical industry, Health informatics, Clinical trial, Design of experiments, Patient recruitment, Datavant, Medable

Medable Inc. , the leading software provider for decentralized clinical trials, and Datavant , the leader in helping healthcare organizations safely connect their data, today announced a partnership that will help clinical trial teams easily integrate multiple data sources to accelerate decentralized trial design, recruitment and data management.

Key Points: 
  • Medable Inc. , the leading software provider for decentralized clinical trials, and Datavant , the leader in helping healthcare organizations safely connect their data, today announced a partnership that will help clinical trial teams easily integrate multiple data sources to accelerate decentralized trial design, recruitment and data management.
  • Medable will integrate Datavants technology into Medables decentralized trials platform, allowing trial teams to combine real-world health records, claims, diagnostic and other data sources with their clinical trial data.
  • Datavant provides us with a broad array of built-in connections to real-world data sources, which can now be combined to yield a more holistic view of patient health than clinical trial data alone.
  • By linking real-world data sources with other sources of study data, clinical trial teams will be better equipped to generate and submit real-world evidence for regulatory assessment.

Trialbee Partners with Datavant to Power Patient-Centric Clinical Trial Recruitment and Engagement

Retrieved on: 
Tuesday, June 23, 2020
Data management, Health, Technology, Software, Clinical trials, Pharmaceutical, Biotechnology, Health, Articles, Clinical research, Pharmaceutical industry, Medical research, Clinical trials, Clinical pharmacology, Design of experiments, Patient recruitment, Patient participation, Trialbee, Datavant

Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, today announced a partnership with Datavant, the leader in privacy-protecting data connectivity, to more effectively and efficiently recruit clinical trial participants.

Key Points: 
  • Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, today announced a partnership with Datavant, the leader in privacy-protecting data connectivity, to more effectively and efficiently recruit clinical trial participants.
  • This unique collaboration will improve specificity and drive the right patients to clinical trials, improving efficiency and time to last patient enrolled.
  • Trialbee will use Datavants open data ecosystem to power its innovative clinical trial recruitment and patient engagement solutions, analyzing de-identified data to determine the characteristics of patients who may be eligible and motivated to participate in a clinical trial.
  • Trialbee is a world leading technology provider in patient matching and engagement, empowering patients to participate in clinical trials as a care option.

MOTIVATE (MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A) Begins Patient Recruitment

Retrieved on: 
Wednesday, June 17, 2020
Health, Haemophilia, Pharmaceutical industry, Clinical trials, Haemophilia A, EudraCT, Patient recruitment, Medical research

MOTIVATE is a multicentre, investigator-initiated study to capture different approaches to the management of patients with haemophilia A and inhibitors.

Key Points: 
  • MOTIVATE is a multicentre, investigator-initiated study to capture different approaches to the management of patients with haemophilia A and inhibitors.
  • MOTIVATE is registered as a non-interventional study in the US ( NCT04023019 ) and as a low-interventional, pragmatic trial in Europe( EudraCT No.
  • Dr Sidonio commented that "It is very exciting that patient recruitment for MOTIVATE has begun.
  • We expect MOTIVATE to provide valuable insights from real-world experience of haemophilia A patients who develop inhibitors to FVIII".